Gut microbiome of a porcine model of metabolic syndrome and HF-pEF
- PMID: 32031871
- DOI: 10.1152/ajpheart.00512.2019
Gut microbiome of a porcine model of metabolic syndrome and HF-pEF
Abstract
Metabolic syndrome (MetS) is a composite of cardiometabolic risk factors, including obesity, dyslipidemia, hypertension, and insulin resistance, with a range of secondary sequelae such as nonalcoholic fatty liver disease and diastolic heart failure. This syndrome has been identified as one of the greatest global health challenges of the 21st century. Herein, we examine whether a porcine model of diet- and mineralocorticoid-induced MetS closely mimics the cardiovascular, metabolic, gut microbiota, and functional metataxonomic phenotype observed in human studies. Landrace pigs with deoxycorticosterone acetate-induced hypertension fed a diet high in fat, salt, and sugar over 12 wk were assessed for hyperlipidemia, hyperinsulinemia, and immunohistologic, echocardiographic, and hemodynamic parameters, as well as assessed for microbiome phenotype and function through 16S rRNA metataxonomic and metabolomic analysis, respectively. All MetS animals developed obesity, hyperlipidemia, insulin resistance, hypertension, fatty liver, structural cardiovascular changes including left ventricular hypertrophy and left atrial enlargement, and increased circulating saturated fatty acid levels, all in keeping with the human phenotype. A reduction in α-diversity and specific microbiota changes at phylum, family, and genus levels were also observed in this model. Specifically, this porcine model of MetS displayed increased abundances of proinflammatory bacteria coupled with increased circulating tumor necrosis factor-α and increased secondary bile acid-producing bacteria, which substantially impacted fibroblast growth factor-19 expression. Finally, a significant decrease in enteroprotective bacteria and a reduction in short-chain fatty acid-producing bacteria were also noted. Together, these data suggest that diet and mineralocorticoid-mediated development of biochemical and cardiovascular stigmata of metabolic syndrome in pigs leads to temporal gut microbiome changes that mimic key gut microbial population signatures in human cardiometabolic disease.NEW & NOTEWORTHY This study extends a prior porcine model of cardiometabolic syndrome to include systemic inflammation, fatty liver, and insulin sensitivity. Gut microbiome changes during evolution of porcine cardiometabolic disease recapitulate those in human subjects with alterations in gut taxa associated with proinflammatory bacteria, bile acid, and fatty acid pathways. This clinical scale model may facilitate design of future interventional trials to test causal relationships between gut dysbiosis and cardiometabolic syndrome at a systemic and organ level.
Keywords: cardiometabolic syndrome; gut microbiome; pig.
Similar articles
-
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25. Free Radic Biol Med. 2017. PMID: 27890642
-
The gut microbiome and metabolic syndrome.J Clin Invest. 2019 Oct 1;129(10):4050-4057. doi: 10.1172/JCI129194. J Clin Invest. 2019. PMID: 31573550 Free PMC article. Review.
-
Enzymatically synthesized α-galactooligosaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with the modulation of gut microbiota.Food Funct. 2021 Jun 8;12(11):4960-4971. doi: 10.1039/d0fo03113e. Food Funct. 2021. PMID: 34100482
-
Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.J Gastroenterol Hepatol. 2016 Aug;31(8):1462-9. doi: 10.1111/jgh.13278. J Gastroenterol Hepatol. 2016. PMID: 26699443
-
Gut microbiota and metabolic syndrome.Chin Med J (Engl). 2020 Apr 5;133(7):808-816. doi: 10.1097/CM9.0000000000000696. Chin Med J (Engl). 2020. PMID: 32106124 Free PMC article. Review.
Cited by
-
A High-Salt Diet Exacerbates Liver Fibrosis through Enterococcus-Dependent Macrophage Activation.Microbiol Spectr. 2023 Feb 14;11(2):e0340322. doi: 10.1128/spectrum.03403-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36786636 Free PMC article.
-
Mapping the global research landscape on nutrition and the gut microbiota: Visualization and bibliometric analysis.World J Gastroenterol. 2022 Jul 7;28(25):2981-2993. doi: 10.3748/wjg.v28.i25.2981. World J Gastroenterol. 2022. PMID: 35978868 Free PMC article. Review.
-
Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction.Biomolecules. 2022 Jul 11;12(7):969. doi: 10.3390/biom12070969. Biomolecules. 2022. PMID: 35883525 Free PMC article. Review.
-
Gut Microbial Signatures of Distinct Trimethylamine N-Oxide Response to Raspberry Consumption.Nutrients. 2022 Apr 15;14(8):1656. doi: 10.3390/nu14081656. Nutrients. 2022. PMID: 35458219 Free PMC article.
-
Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation.Cardiovasc Res. 2022 Dec 29;118(16):3171-3182. doi: 10.1093/cvr/cvac057. Cardiovasc Res. 2022. PMID: 35420126 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous